Literature DB >> 1545652

Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment.

C A Megerian1, J E Arnold, M Berger.   

Abstract

Angioedema is a problem that the otolaryngologist-head and neck surgeon is often asked to treat. This report concerns 17 patients admitted for care during a 5-year period. At their initial presentation, 94% of these patients manifested signs and symptoms of angioedema in the head and neck; three of them required urgent tracheotomy or intubation. As treatment of complement-mediated angioedema is distinct, an etiology-specific diagnostic and treatment protocol is presented. Of the patients, 35% had recent initiation of angiotensin-converting enzyme (ACE) inhibitor therapy for hypertension, and 6% demonstrated classic hereditary angioedema. However, the majority of them (59%) had unclear etiologies for their symptoms. Since angioedema is the final result of several possible abnormalities, a thorough knowledge of the differential diagnosis and clinical presentation is vital to patient management.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545652     DOI: 10.1288/00005537-199203000-00005

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  ACE inhibitor use and severe angioedema.

Authors:  A Murray; J Crowther
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

Review 2.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  Angioedema due to ACE inhibitors: increased risk in patients of African origin.

Authors:  C R Gibbs; G Y Lip; D G Beevers
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

4.  [Life-threatening swelling of the tongue in antihypertensive therapy with ACE inhibitors].

Authors:  A Brandes; R Bschorer; G Gehrke; G Kessler; R Schmelzle
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

Review 5.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

6.  Recurrent angioedema and urticaria.

Authors:  P C Bishop; J J Wisnieski; J Christensen
Journal:  West J Med       Date:  1993-11

7.  Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Cheng Gang; Christopher J Lindsell; Joseph Moellman; Wesley Sublett; Kim Hart; Sean Collins; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

8.  Hereditary angioedema-presenting as recurrent abdominal pain.

Authors:  Madhura Milind Killedar; Anand S Malani
Journal:  Indian J Surg       Date:  2011-04-12       Impact factor: 0.656

9.  [Is tracheotomy of angioedema associated with ACE-inhibitor therapy?].

Authors:  T Schröder; F Sachse; C Rudack
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 10.  Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?

Authors:  Domenic A Sica; Henry R Black
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.